Genta To File Complaint With FDA Over Statistical Analysis Of Genasense Data
This article was originally published in The Pink Sheet Daily
Executive Summary
Complaint relates to 2004 analysis of Genasense progression-free survival data in melanoma, presented to the Oncologic Drugs Advisory Committee.